MedPath

L-Ornithine-L-Aspartate

Generic Name
L-Ornithine-L-Aspartate

Overview

No overview information available.

Background

No background information available.

Indication

适用急、慢性肝病(各型肝炎、肝硬化、脂肪肝及肝炎后综合征)引起的血氨升高及肝性脑病。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Ornithine Aspartate Injection
国药准字H20203383
化学药品
注射剂
8/5/2020
Ornithine Aspartate Injection
国药准字H20213366
化学药品
注射剂
5/19/2021
Ornithine Aspartate Injection
国药准字H20203173
化学药品
注射剂
4/23/2020
Ornithine Aspartate Injection
国药准字H20213903
化学药品
注射剂
11/30/2021
Ornithine Aspartate Injection
国药准字H20183342
化学药品
注射剂
7/5/2023
Ornithine Aspartate Injection
国药准字H20183228
化学药品
注射剂
6/8/2023
Ornithine Aspartate Injection
国药准字H20203323
化学药品
注射剂
7/21/2020
Ornithine Aspartate Injection
国药准字HJ20130430
化学药品
注射剂
7/3/2023
Ornithine Aspartate Injection
国药准字H20203188
化学药品
注射剂
5/7/2020
Ornithine Aspartate Injection
国药准字H20223733
化学药品
注射剂
10/11/2022

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath